Aandeel 603566 PULIKE BIOLOGICAL ENGINEERING, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Pulike Biological Engineering, Inc.

Aandelen

603566

CNE1000025N0

slotkoers Shanghai S.E.
Andere beurzen
 00:00:00 25-04-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
17,89 CNY +0,28% Intraday-grafiek van Pulike Biological Engineering, Inc. +4,62% -21,02%
25/04 Pulike Biological Engineering, Inc. Rapporteert winstresultaten voor het eerste kwartaal eindigend op 31 maart 2024 CI
25/04 Pulike Biological Engineering, Inc. Rapporteert winstresultaten voor het volledige jaar eindigend op 31 december 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Pulike Biological Engineering, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Pulike Biological Engineering, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Tranche Update on Pulike Biological Engineering, Inc.'s Equity Buyback Plan announced on November 14, 2023.
Tranche Update on Pulike Biological Engineering, Inc.'s Equity Buyback Plan announced on November 14, 2023.
Pulike Biological's Vaccine for Feline Respiratory Diseases Passes Chinese Emergency Evaluation
Pulike Biological Engineering, Inc. announces an Equity Buyback for CNY 120 million worth of its shares.
Pulike Biological Engineering, Inc. authorizes a Buyback Plan.
Pulike Biological Engineering, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
Pulike Biological Engineering, Inc.(XSSC:603566) added to S&P Global BMI Index
Pulike Biological Engineering, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
Pulike Biological Engineering, Inc. agreed to acquire Luoyang Lechong Health Technology Co., Ltd. from Shiji Mengbang Information Technology Co., Ltd. and Luoyang Jidi Biotechnology Center (Limited Partnership) for CNY 23.5 million.
Pulike Biological Engineering Gets Certificate for Respiratory Drug for Chickens
Pulike Biological Engineering, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Pulike Biological Engineering, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Frontier IP investee develops vaccine candidate for Streptococcus suis
Pulike Biological Engineering, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022
Pulike Biological Engineering Unit’s New Drug Wins Registration Certificate
Pulike Biological Engineering, Inc. announced that it has received CNY 897.999976 million in funding from a group of investors
Pulike Biological Engineering, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022
CAHIC ZENAQ Animal Pharmaceutical Co., Ltd announced that it expects to receive CNY 82.72 million in funding from China Animal Husbandry Industry Co., Ltd., Pulike Biological Engineering, Inc.
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers 603566
  4. Nieuws Pulike Biological Engineering, Inc.
  5. Andere talen